Tranexamic acid for trauma

The Lancet

Volumn 376, Issue 9746, 2010, Pages 1050-

  Yeguiayan, Jean Michel ^a   Rosencher, Nadia ^b   Freysz, Marc ^a  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FRESH FROZEN PLASMA; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

BLEEDING; BLOOD TRANSFUSION; DRUG COST; DRUG EFFICACY; DRUG SAFETY; HUMAN; INJURY; INJURY SEVERITY; LETTER; MORTALITY; PATIENT SELECTION; PRIORITY JOURNAL; THROMBOSIS; COMPLICATION; HEMORRHAGE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SELECTION BIAS;

ANTIFIBRINOLYTIC AGENTS; HEMORRHAGE; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SELECTION BIAS; THROMBOSIS; TRANEXAMIC ACID; WOUNDS AND INJURIES;

EID: 77957192968     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)61478-X     Document Type: Letter

References (5)

1. CRASH-2 trial collaborators Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial Lancet 376 2010 23 32
2. PA Carli, JE de la Coussaye, B Riou Immediate versus delayed fluid resuscitation in patients with trauma N Engl J Med 332 1995 682
3. AB Nathens, FP Brunet, RV Maier Development of trauma systems and effect on outcomes after injury Lancet 363 2004 1794 1801 (Pubitemid 38698385)
4. R Rossaint, B Bouillon, V Cerny Management of bleeding following major trauma: an updated European guideline Crit Care 14 2010 R52
5. WH Geerts, RM Jay, KI Code A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma N Engl J Med 335 1996 701 707 (Pubitemid 26287356)